Christel Vangestel
Christel Vangestel
Postdoctoral fellowship, University Hospital Antwerp, University of Antwerp
Verified email at uantwerpen.be
Title
Cited by
Cited by
Year
Molecular imaging of hypoxia with radiolabelled agents
G Mees, R Dierckx, C Vangestel, C Van de Wiele
European journal of nuclear medicine and molecular imaging 36 (10), 1674-1686, 2009
2082009
Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors
T Vandamme, M Beyens, KO de Beeck, F Dogan, PM van Koetsveld, ...
British journal of cancer 114 (6), 650-658, 2016
482016
99mTc-(CO) 3 His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab
C Vangestel, C Van de Wiele, N Van Damme, S Staelens, P Pauwels, ...
Journal of Nuclear Medicine 52 (11), 1786-1794, 2011
402011
In vivo imaging of apoptosis in oncology: an update
C Vangestel, M Peeters, G Mees, R Oltenfreiter, HH Boersma, PH Elsinga, ...
Molecular imaging 10 (5), 7290.2010. 00058, 2011
402011
Characterization of [99mTc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis
F Elvas, C Vangestel, S Rapic, J Verhaeghe, B Gray, K Pak, S Stroobants, ...
Molecular imaging and biology 17 (6), 838-847, 2015
382015
Forcing cancer cells to commit suicide
C Vangestel, C Van de Wiele, G Mees, M Peeters
Cancer Biotherapy and Radiopharmaceuticals 24 (4), 395-407, 2009
372009
ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice
A Kurdi, M Cleenewerck, C Vangestel, S Lyssens, W Declercq, ...
Biochemical pharmacology 138, 150-162, 2017
292017
99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET
F Elvas, J Boddaert, C Vangestel, K Pak, B Gray, S Kumar-Singh, ...
Journal of Nuclear Medicine 58 (4), 665-670, 2017
262017
Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator
T Van Den Broeck, F Stevenaert, S Taveirne, V Debacker, C Vangestel, ...
Blood, The Journal of the American Society of Hematology 112 (13), 5046-5051, 2008
252008
Early prediction of tumor response to treatment: preclinical validation of 99mTc-duramycin
F Elvas, C Vangestel, K Pak, P Vermeulen, B Gray, S Stroobants, ...
Journal of Nuclear Medicine 57 (5), 805-811, 2016
242016
Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal …
C Vangestel, C Van de Wiele, G Mees, K Mertens, S Staelens, ...
Molecular imaging 11 (2), 7290.2011. 00034, 2012
242012
FDG uptake in primary squamous cell carcinoma of the head and neck
P Deron, C Vangestel, I Goethals, A De Potter, M Peeters, H Vermeersch, ...
Nuklearmedizin 50 (01), 15-21, 2011
222011
In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells
C Vangestel, M Peeters, R Oltenfreiter, Y D'Asseler, S Staelens, ...
Nuclear medicine and biology 37 (8), 965-975, 2010
222010
Pharmacologic Activation of Tumor Hypoxia: A Means to Increase Tumor 2-Deoxy-2-[18F]Fluoro-D-Glucose Uptake?
G Mees, R Dierckx, C Vangestel, D Laukens, N Van Damme, CV de Wiele
Molecular imaging 12 (1), 2013
172013
Carbonic Anhydrase IX Expression Correlates with FDG Uptake by Primary Non–Small Cell Lung Cancer
G Mees, C Vangestel, R Dierckx, P Pauwels, JV Meerbeeck, ...
Cancer Biotherapy and Radiopharmaceuticals 25 (2), 149-154, 2010
172010
Development of a novel antibody–tetrazine conjugate for bioorthogonal pretargeting
A Maggi, E Ruivo, J Fissers, C Vangestel, S Chatterjee, J Joossens, ...
Organic & biomolecular chemistry 14 (31), 7544-7551, 2016
162016
Evaluation of [18F]CP18 as a Substrate-Based Apoptosis Imaging Agent for the Assessment of Early Treatment Response in Oncology
S Rapic, C Vangestel, F Elvas, J Verhaeghe, T Van den Wyngaert, ...
Molecular Imaging and Biology 19 (4), 560-569, 2017
122017
Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using 18F-FDG PET/CT for Monitoring Treatment Response
R Capistrano, C Vangestel, A Wouters, Y Dockx, P Pauwels, S Stroobants, ...
Cancer Biotherapy and Radiopharmaceuticals 31 (3), 99-109, 2016
122016
Baseline [18F]FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer …
S De Bruycker, C Vangestel, T Van den Wyngaert, A Wouters, P Pauwels, ...
Molecular Imaging and Biology 18 (4), 606-616, 2016
112016
Preclinical evaluation of [111In]MICA‐401, an activity‐based probe for SPECT imaging of in vivo uPA activity
C Vangestel, D Thomae, J Van Soom, J Ides, L Wyffels, P Pauwels, ...
Contrast media & molecular imaging 11 (6), 448-458, 2016
92016
The system can't perform the operation now. Try again later.
Articles 1–20